Pharmacological Implications of lnterleukin-5 in the Control of Eosinophilia
- 1 January 1992
- book chapter
- Published by Elsevier
- Vol. 23, 163-177
- https://doi.org/10.1016/s1054-3589(08)60965-5
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Interaction of interleukin-5 with its receptors on murine leukemic BCL1 cells and its implication in biological activityCellular Immunology, 1990
- Characterization of the murine interleukin 5 receptor by using a monoclonal antibodyInternational Immunology, 1990
- A long-range restriction map of the interleukin-4 and interleukin-5 linkage group on chromosome 5Genomics, 1990
- Interactions of Hemopoietic Cytokines on Differentiation of HL-60 CellsInternational Archives of Allergy and Immunology, 1990
- Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factorEuropean Journal of Biochemistry, 1988
- The regulation of human eosinophil function by cytokinesImmunology Today, 1987
- Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.The Journal of Experimental Medicine, 1986
- IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMAThe Lancet, 1982
- Conditions controlling the proliferation of haemopoietic stem cells in vitroJournal of Cellular Physiology, 1977
- MECHANISM OF EOSINOPHILIAThe Journal of Experimental Medicine, 1970